Login / Signup

Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412-2421.

José-Miguel González-ClementeGemma LlauradóAlbert CanoOlga Giménez-PalopLara AlbertJoan Josep Vendrell
Published in: Diabetes care (2023)
Keyphrases
  • cardiovascular disease
  • genome wide
  • cell therapy
  • stem cells
  • dna methylation
  • childhood cancer